US Patent Issued on Sept. 1 for "Antiviral agent for combined therapy of COVID-19 (SARS-CoV-2)" (American, Russian Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,883, issued on Sept. 1.

"Antiviral agent for combined therapy of COVID-19 (SARS-CoV-2)" was invented by Alexandre Vasilievich Ivachtchenko (Hallandale, Fla.), Nikolay Filippovich Savchuk (Rancho Santa Fe, Calif.), Alena Alexandrovna Ivachtchenko (Hallandale, Fla.), Vladimir Grigorievich Loginov (Moscow), Mikhail Topr (New York) and Andrey Alexandrovich Ivashchenko (Moscow).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to a novel anti-coronavirus agent for COVID-19 (SARS-CoV-2) combination therapy. The agent comprises, in a therapeutically effective amount and ratio, aprotinin (APR) or a medicinal drug based thereon and a SARS-...